367
Views
20
CrossRef citations to date
0
Altmetric
Reviews

The financial burden of cancer care: do patients in the US know what to expect?

References

  • Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011;12(10):933-80
  • Keehan SP, Sisko AM, Truffer CJ, et al. National health spending projections through 2020: economic recovery and reform drive faster spending growth. Health Aff (Millwood) 2011;30(8):1594-605
  • Ramsey S, Blough D, Kirchhoff A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 2013;32(6):1143-52
  • Zafar SY, Peppercorn JM, Schrag D, et al. The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient’s Experience. Oncologist 2013
  • U.S. Census Bureau, Statistical Abstract of the United States: 2012 (131st Edition) Washington, DC, 2011. Available from: www.census.gov/compendia/statab/
  • DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States. BUREAU USC, editor. 2012
  • Schoen C, Hayes SL, Riley P. The Affordable Care Act’s new tools and resources to improve health and care for low-income families across the country. Issue Brief (Commonw Fund) 2013;26:1-14
  • Young RA, DeVoe JE. Who will have health insurance in the future? An updated projection. Ann Fam Med 2012;10(2):156-62
  • Davidoff AJ, Erten M, Shaffer T, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer 2013;119(6):1257-65
  • Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev 2011;20(10):2006-14
  • World Development Indicators database, World Bank. Database updated on 1 July 2014. Available from: http://data.worldbank.org/data-catalog/world-development-indicators [Last accessed 5 August 2014]
  • Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013;14(12):1165-74
  • Syse A, Tretli S, Kravdal O. The impact of cancer on spouses’ labor earnings: a population-based study. Cancer 2009;115(18 Suppl):4350-61
  • Mehnert A, de Boer A, Feuerstein M. Employment challenges for cancer survivors. Cancer 2013(119 Suppl 11):2151-9
  • Earle CC, Chretien Y, Morris C, et al. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol 2010;28(10):1700-5
  • Hassett MJ, O’Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer 2009;115(12):2775-82
  • Peppercorn J, Zafar SY, Houck K, et al. Does comparative effectiveness research promote rationing of cancer care? Lancet Oncol 2014;15(3):e132-8
  • Baselga J, Cortes J, Kim SB, et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 2012;366(2):109-19
  • Babigumira JB. Projecting the cost-effectiveness of pertuzumab with trastuzumab and docetaxel in the neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early breast cancer. J Clin Oncol 2014;32(5 Suppl):abstract 642
  • Peppercorn J AA, Zaas DW, George D. Rationing in Urologic Oncology: lessons from Sipuleucel-T for Advanced Prostate Cancer. Urologic Oncology. In Press 2012
  • Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363(8):711-23
  • Swanson SJ, Meyers BF, Gunnarsson CL, et al. Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg 2012;93(4):1027-32
  • Greenup RA, Camp MS, Taghian AG, et al. Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol 2012;19(10):3275-81
  • Cannon RM, Scoggins CR, Callender GG, et al. Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol 2013;20(9):2887-92
  • Bestvina CM, Zullig LL, Rushing C, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 2014;10(3):162-7
  • Irwin B. G K, I A et al. Patient experience and attitudes towards addressing the cost of breast cancer care. Oncologist 2014; In Press
  • Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 2012;30(14):1608-14
  • Jagsi R, Pottow JA, Griffith KA, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 2014;32(12):1269-76
  • Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff (Millwood) 2014;33(6):1024-31
  • Guy GP Jr, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 2013;31(30):3749-57
  • Anderson KR, Chambers CR, Lam N, et al. Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia. J Oncol Pharm Pract 2014. [Epub ahead of print]
  • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11(1):44-7
  • Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126(2):529-37
  • Neugut AI, Subar M, Wilde ET, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 2011;29(18):2534-42
  • Dusetzina SB, Winn AN, Abel GA, et al. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 2014;32(4):306-11
  • Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008;58(1):9-31
  • Chino F, Peppercorn J, Taylor DH Jr, et al. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist 2014;19(4):414-20
  • Kim P. Cost of cancer care: the patient perspective. J Clin Oncol 2007;25(2):228-32
  • Reinhardt UE. The disruptive innovation of price transparency in health care. Jama 2013;310(18):1927-8
  • Cutler D, Dafny L. Designing transparency systems for medical care prices. N Engl J Med 2011;364(10):894-5
  • Kliff S. One hospital charges $8,000 — another, $38,000. Available from: www.washingtonpost.com/blogs/wonkblog/wp/2013/05/08/one-hospital-charges-8000-another-38000/
  • Kullgren JT, Duey KA, Werner RM. A census of state health care price transparency websites. Jama 2013;309(23):2437-8
  • Yabroff KR, Warren JL, Banthin J, et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care 2009;47(7 Suppl 1):S64-9
  • Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med 2007;4(9):e283
  • Pilkinton M, Brustman L. A survey of physician knowledge and attitudes on hospital billing costs. Obstet Gynecol 2014(123 Suppl 1):20S-1S
  • Neumann PJ, Palmer JA, Nadler E, et al. Cancer therapy costs influence treatment: a national survey of oncologists. Health Aff (Millwood) 2010;29(1):196-202
  • Schrag D, Hanger M. Medical oncologists’ views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 2007;25(2):233-7
  • Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009;27(23):3868-74
  • Love D, Custer W, Miller P. All-payer claims databases: state initiatives to improve health care transparency. Issue Brief (Commonw Fund) 2010;99:1-14
  • Korenstein D, Kale M, Levinson W. Teaching value in academic environments: shifting the ivory tower. Jama 2013;310(16):1671-2
  • Wilensky GR. Why 2014 may be the year for physician payment reform. Healthc Financ Manage 2014;68(3):30-2
  • Schnipper LE. Quality oncology practice initiative: an approach to solving the value equation. J Oncol Pract 2014;10(3):219-20
  • Schnipper LE. The rising cost of cancer care: physicians take charge. J Oncol Pract 2012;8(4):e87-8
  • Haviland JS, Owen JR, Dewar JA, et al.The UK. Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14(11):1086-94
  • Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;81(1):59-68
  • Chen RC, Falchook AD, Hendrix LH, Jagsi R. Adoption of hypofractionated radiotherapy for early-stage invasive breast cancer after publication of randomized trials. J Clin Oncol 2014;32(5 Suppl):abstract 6522
  • Peppercorn JM, Smith TJ, Helft PR, et al. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 2011;29(6):755-60
  • Major US Health plans agree to give consumers free access to timely information about health care prices to foster greater transparency. Available from: www.healthcostinstitute.org/news-and-events/major-us-health-plans-agree-give-consumers-free-access-timely-information-about-heal [Last accessed 20 June 2014]
  • Schilsky RL, Michels DL, Kearbey AH, et al. Building a Rapid Learning Health Care System for Oncology: the Regulatory Framework of CancerLinQ. J Clin Oncol 2014;32(22):2373-9
  • Arozullah AM, Calhoun EA, Wolf M, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2004;2(3):271-8
  • Markman M, Luce R. Impact of the cost of cancer treatment: an internet-based survey. J Oncol Pract 2010;6(2):69-73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.